Full View

20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings

TG Rhee, M Olfson, AA Nierenberg… - American Journal of …, 2020 - Am Psychiatric Assoc
Objective: Pharmacological options for treating bipolar disorder have increased over the
past 20 years, with several second-generation antipsychotics receiving regulatory approval …
被引用次数：175 相关文章

[引用][C] 20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings

TG Rhee, M Olfson, AA Nierenberg… - American Journal of …, 2020 - cir.nii.ac.jp
20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in
Outpatient Care Settings | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
[HTML] nih.gov

[HTML][HTML] 20-years Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings

TG Rhee, M Olfson, AA Nierenberg… - The American journal of …, 2020 - ncbi.nlm.nih.gov
Pharmacological options for treating bipolar disorder have increased over the past 20 years,
with several second-generation antipsychotics receiving regulatory approval in the 1990s …

20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings.

TG Rhee, M Olfson, AA Nierenberg… - The American Journal …, 2020 - europepmc.org
Objective Pharmacological options for treating bipolar disorder have increased over the past
20 years, with several second-generation antipsychotics receiving regulatory approval in the …

20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings

TG Rhee, M Olfson, AA Nierenberg… - … American journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective Pharmacological options for treating bipolar disorder have increased over the past
20 years, with several second-generation antipsychotics receiving regulatory approval in the …